SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-205630
Filing Date
2023-08-08
Accepted
2023-08-08 08:27:52
Documents
14
Period of Report
2023-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d537671d8k.htm   iXBRL 8-K 28529
2 EX-1.1 d537671dex11.htm EX-1.1 166963
3 EX-5.1 d537671dex51.htm EX-5.1 7829
  Complete submission text file 0001193125-23-205630.txt   380773

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pepg-20230808.xsd EX-101.SCH 2834
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pepg-20230808_lab.xml EX-101.LAB 18736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pepg-20230808_pre.xml EX-101.PRE 11696
8 EXTRACTED XBRL INSTANCE DOCUMENT d537671d8k_htm.xml XML 3456
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 231149479
SIC: 2834 Pharmaceutical Preparations